NCT04541381View on ClinicalTrials.gov

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

NARecruitingINTERVENTIONAL
Enrollment

860

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

October 1, 2027

Study Completion Date

March 31, 2028

Conditions
Gastrointestinal CancerHead and Neck CancerDihydropyrimidine Dehydrogenase DeficiencyUGT1A1 Gene MutationBreast Cancer
Interventions
OTHER

Availability of clinical decision support based on pharmacogenomic results.

Availability of clinical decision support based on pharmacogenomic results. These results are designed to provide specific dosing information based on the participant's unique genetics/genomics.

Trial Locations (1)

60637

RECRUITING

University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER